Market Research Logo

Drug Discovery Technologies - Global Market Outlook (2016-2022)

Drug Discovery Technologies - Global Market Outlook (2016-2022)

According to Stratistics MRC, the Global Drug Discovery Technologies market is estimated at $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. Rise in new diseases and growing demand for therapeutics in various diseases are the factors driving the market growth. Stringent regulations and high initial cost associated with drug discovery are the factors hampering the market. Discovering drugs for diseases like Parkinson disease, cancer, nervous disorders is the opportunity for the market growth.

Some of the key players in the market include Bayer Healthcare AG, Roche Holding AG, Boehringer Ingelheim GmbH, Illumina Inc., Millennium Pharmaceuticals, Inc., Abbott Laboratories, Beckman Coulter Inc., Aviva Biosciences Corp., Bio-Rad Laboratories, Inc., Novartis AG, Charles River Laboratories International, Inc., Evotec AG, Merck & Co., Inc., Viva Biotech Ltd, Sri Biosciences, GE Healthcare Ltd., Qiagen N.V. and Quantum Pharmaceuticals.

Technologies Covered:
DNA & Protein Microarrays
High Throughput Screening
Genomics
Biochips
Proteomic Technologies
Microfluidics
Metabolomics
Pharmacogenomics
Gel Electrophoresis
Bioanalytical Instruments
Chromatography
Bioinformatics
QPCR
Combinatorial Chemistry
Mass Spectrometry
Nanotechnology
RNAi
Nucleic Acid Isolation
Protein
Epigenetics
Cell Based Assays
Laboratory Information Management Systems

Applications Covered:
Parkinson’s disease
Cancer
Central Nervous System Disorders
Cardiovascular Diseases
Other Applications

End Users Covered:
Biopharmaceutical Companies
Research Institutes
Biotech Companies
Pharmaceutical Companies

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Drug Discovery Technologies Market, By Technology
5.1 Introduction
5.2 DNA & Protein Microarrays
5.3 High Throughput Screening
5.4 Genomics
5.5 Biochips
5.6 Proteomic Technologies
5.7Microfluidics
5.8 Metabolomics
5.9 Pharmacogenomics
5.10 Gel Electrophoresis
5.11 Bioanalytical Instruments
5.12 Chromatography
5.13 Bioinformatics
5.14 QPCR
5.15 Combinatorial Chemistry
5.16 Mass Spectrometry
5.17 Nanotechnology
5.18 RNAi
5.19 Nucleic Acid Isolation
5.20 Protein
5.21 Epigenetics
5.22 Cell Based Assays
5.23 Laboratory Information Management Systems
6 Global Drug Discovery Technologies Market, By Application
6.1 Introduction
6.2 Parkinson’s disease
6.3 Cancer
6.4 Central Nervous System Disorders
6.5 Cardiovascular Diseases
6.6 Other Applications
7 Global Drug Discovery Technologies Market, By End User
7.1 Introduction
7.2 Biopharmaceutical Companies
7.3 Research Institutes
7.4 Biotech Companies
7.5 Pharmaceutical Companies
8 Global Drug Discovery Technologies Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Bayer Healthcare AG
10.2 Roche Holding AG
10.3 Boehringer Ingelheim GmbH
10.4 Illumina Inc.
10.5 Millennium Pharmaceuticals, Inc.
10.6 Abbott Laboratories
10.7 Beckman Coulter Inc.
10.8 Aviva Biosciences Corp.
10.9 Bio-Rad Laboratories, Inc.
10.10 Novartis AG
10.11 Charles River Laboratories International, Inc.
10.12 Evotec AG
10.13 Merck & Co., Inc.
10.14 Viva Biotech Ltd
10.15 Sri Biosciences
10.16 GE Healthcare Ltd.
10.17 Qiagen N.V.
10.18 Quantum Pharmaceuticals
List of Tables
Table 1 Global Drug Discovery Technologies Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Drug Discovery Technologies Market Outlook, By Technology (2013-2022) ($MN)
Table 3 Global Drug Discovery Technologies Market Outlook, By DNA & Protein Microarrays (2013-2022) ($MN)
Table 4 Global Drug Discovery Technologies Market Outlook, By High Throughput Screening (2013-2022) ($MN)
Table 5 Global Drug Discovery Technologies Market Outlook, By Genomics (2013-2022) ($MN)
Table 6 Global Drug Discovery Technologies Market Outlook, By Biochips (2013-2022) ($MN)
Table 7 Global Drug Discovery Technologies Market Outlook, By Proteomic Technologies (2013-2022) ($MN)
Table 8 Global Drug Discovery Technologies Market Outlook, ByMicrofluidics (2013-2022) ($MN)
Table 9 Global Drug Discovery Technologies Market Outlook, By Metabolomics (2013-2022) ($MN)
Table 10 Global Drug Discovery Technologies Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
Table 11 Global Drug Discovery Technologies Market Outlook, By Gel Electrophoresis (2013-2022) ($MN)
Table 12 Global Drug Discovery Technologies Market Outlook, By Bioanalytical Instruments (2013-2022) ($MN)
Table 13 Global Drug Discovery Technologies Market Outlook, By Chromatography (2013-2022) ($MN)
Table 14 Global Drug Discovery Technologies Market Outlook, By Bioinformatics (2013-2022) ($MN)
Table 15 Global Drug Discovery Technologies Market Outlook, By QPCR (2013-2022) ($MN)
Table 16 Global Drug Discovery Technologies Market Outlook, By Combinatorial Chemistry (2013-2022) ($MN)
Table 17 Global Drug Discovery Technologies Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
Table 18 Global Drug Discovery Technologies Market Outlook, By Nanotechnology (2013-2022) ($MN)
Table 19 Global Drug Discovery Technologies Market Outlook, By RNAi (2013-2022) ($MN)
Table 20 Global Drug Discovery Technologies Market Outlook, By Nucleic Acid Isolation (2013-2022) ($MN)
Table 21 Global Drug Discovery Technologies Market Outlook, By Protein (2013-2022) ($MN)
Table 22 Global Drug Discovery Technologies Market Outlook, By Epigenetics (2013-2022) ($MN)
Table 23 Global Drug Discovery Technologies Market Outlook, By Cell Based Assays (2013-2022) ($MN)
Table 24 Global Drug Discovery Technologies Market Outlook, By Laboratory Information Management Systems (2013-2022) ($MN)
Table 25 Global Drug Discovery Technologies Market Outlook, By Application (2013-2022) ($MN)
Table 26 Global Drug Discovery Technologies Market Outlook, By Parkinson’s disease (2013-2022) ($MN)
Table 27 Global Drug Discovery Technologies Market Outlook, By Cancer (2013-2022) ($MN)
Table 28 Global Drug Discovery Technologies Market Outlook, By Central Nervous System Disorders (2013-2022) ($MN)
Table 29 Global Drug Discovery Technologies Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 30 Global Drug Discovery Technologies Market Outlook, By Other Applications (2013-2022) ($MN)
Table 31 Global Drug Discovery Technologies Market Outlook, By End User (2013-2022) ($MN)
Table 32 Global Drug Discovery Technologies Market Outlook, By Biopharmaceutical Companies (2013-2022) ($MN)
Table 33 Global Drug Discovery Technologies Market Outlook, By Research Institutes (2013-2022) ($MN)
Table 34 Global Drug Discovery Technologies Market Outlook, By Biotech Companies (2013-2022) ($MN)
Table 35 Global Drug Discovery Technologies Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Table 36 North America Drug Discovery Technologies Market Outlook, By Country (2013-2022) ($MN)
Table 37 North America Drug Discovery Technologies Market Outlook, By Technology (2013-2022) ($MN)
Table 38 North America Drug Discovery Technologies Market Outlook, By DNA & Protein Microarrays (2013-2022) ($MN)
Table 39 North America Drug Discovery Technologies Market Outlook, By High Throughput Screening (2013-2022) ($MN)
Table 40 North America Drug Discovery Technologies Market Outlook, By Genomics (2013-2022) ($MN)
Table 41 North America Drug Discovery Technologies Market Outlook, By Biochips (2013-2022) ($MN)
Table 42 North America Drug Discovery Technologies Market Outlook, By Proteomic Technologies (2013-2022) ($MN)
Table 43 North America Drug Discovery Technologies Market Outlook, ByMicrofluidics (2013-2022) ($MN)
Table 44 North America Drug Discovery Technologies Market Outlook, By Metabolomics (2013-2022) ($MN)
Table 45 North America Drug Discovery Technologies Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
Table 46 North America Drug Discovery Technologies Market Outlook, By Gel Electrophoresis (2013-2022) ($MN)
Table 47 North America Drug Discovery Technologies Market Outlook, By Bioanalytical Instruments (2013-2022) ($MN)
Table 48 North America Drug Discovery Technologies Market Outlook, By Chromatography (2013-2022) ($MN)
Table 49 North America Drug Discovery Technologies Market Outlook, By Bioinformatics (2013-2022) ($MN)
Table 50 North America Drug Discovery Technologies Market Outlook, By QPCR (2013-2022) ($MN)
Table 51 North America Drug Discovery Technologies Market Outlook, By Combinatorial Chemistry (2013-2022) ($MN)
Table 52 North America Drug Discovery Technologies Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
Table 53 North America Drug Discovery Technologies Market Outlook, By Nanotechnology (2013-2022) ($MN)
Table 54 North America Drug Discovery Technologies Market Outlook, By RNAi (2013-2022) ($MN)
Table 55 North America Drug Discovery Technologies Market Outlook, By Nucleic Acid Isolation (2013-2022) ($MN)
Table 56 North America Drug Discovery Technologies Market Outlook, By Protein (2013-2022) ($MN)
Table 57 North America Drug Discovery Technologies Market Outlook, By Epigenetics (2013-2022) ($MN)
Table 58 North America Drug Discovery Technologies Market Outlook, By Cell Based Assays (2013-2022) ($MN)
Table 59 North America Drug Discovery Technologies Market Outlook, By Laboratory Information Management Systems (2013-2022) ($MN)
Table 60 North America Drug Discovery Technologies Market Outlook, By Application (2013-2022) ($MN)
Table 61 North America Drug Discovery Technologies Market Outlook, By Parkinson’s disease (2013-2022) ($MN)
Table 62 North America Drug Discovery Technologies Market Outlook, By Cancer (2013-2022) ($MN)
Table 63 North America Drug Discovery Technologies Market Outlook, By Central Nervous System Disorders (2013-2022) ($MN)
Table 64 North America Drug Discovery Technologies Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 65 North America Drug Discovery Technologies Market Outlook, By Other Applications (2013-2022) ($MN)
Table 66 North America Drug Discovery Technologies Market Outlook, By End User (2013-2022) ($MN)
Table 67 North America Drug Discovery Technologies Market Outlook, By Biopharmaceutical Companies (2013-2022) ($MN)
Table 68 North America Drug Discovery Technologies Market Outlook, By Research Institutes (2013-2022) ($MN)
Table 69 North America Drug Discovery Technologies Market Outlook, By Biotech Companies (2013-2022) ($MN)
Table 70 North America Drug Discovery Technologies Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Table 71 Europe Drug Discovery Technologies Market Outlook, By Country (2013-2022) ($MN)
Table 72 Europe Drug Discovery Technologies Market Outlook, By Technology (2013-2022) ($MN)
Table 73 Europe Drug Discovery Technologies Market Outlook, By DNA & Protein Microarrays (2013-2022) ($MN)
Table 74 Europe Drug Discovery Technologies Market Outlook, By High Throughput Screening (2013-2022) ($MN)
Table 75 Europe Drug Discovery Technologies Market Outlook, By Genomics (2013-2022) ($MN)
Table 76 Europe Drug Discovery Technologies Market Outlook, By Biochips (2013-2022) ($MN)
Table 77 Europe Drug Discovery Technologies Market Outlook, By Proteomic Technologies (2013-2022) ($MN)
Table 78 Europe Drug Discovery Technologies Market Outlook, ByMicrofluidics (2013-2022) ($MN)
Table 79 Europe Drug Discovery Technologies Market Outlook, By Metabolomics (2013-2022) ($MN)
Table 80 Europe Drug Discovery Technologies Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
Table 81 Europe Drug Discovery Technologies Market Outlook, By Gel Electrophoresis (2013-2022) ($MN)
Table 82 Europe Drug Discovery Technologies Market Outlook, By Bioanalytical Instruments (2013-2022) ($MN)
Table 83 Europe Drug Discovery Technologies Market Outlook, By Chromatography (2013-2022) ($MN)
Table 84 Europe Drug Discovery Technologies Market Outlook, By Bioinformatics (2013-2022) ($MN)
Table 85 Europe Drug Discovery Technologies Market Outlook, By QPCR (2013-2022) ($MN)
Table 86 Europe Drug Discovery Technologies Market Outlook, By Combinatorial Chemistry (2013-2022) ($MN)
Table 87 Europe Drug Discovery Technologies Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
Table 88 Europe Drug Discovery Technologies Market Outlook, By Nanotechnology (2013-2022) ($MN)
Table 89 Europe Drug Discovery Technologies Market Outlook, By RNAi (2013-2022) ($MN)
Table 90 Europe Drug Discovery Technologies Market Outlook, By Nucleic Acid Isolation (2013-2022) ($MN)
Table 91 Europe Drug Discovery Technologies Market Outlook, By Protein (2013-2022) ($MN)
Table 92 Europe Drug Discovery Technologies Market Outlook, By Epigenetics (2013-2022) ($MN)
Table 93 Europe Drug Discovery Technologies Market Outlook, By Cell Based Assays (2013-2022) ($MN)
Table 94 Europe Drug Discovery Technologies Market Outlook, By Laboratory Information Management Systems (2013-2022) ($MN)
Table 95 Europe Drug Discovery Technologies Market Outlook, By Application (2013-2022) ($MN)
Table 96 Europe Drug Discovery Technologies Market Outlook, By Parkinson’s disease (2013-2022) ($MN)
Table 97 Europe Drug Discovery Technologies Market Outlook, By Cancer (2013-2022) ($MN)
Table 98 Europe Drug Discovery Technologies Market Outlook, By Central Nervous System Disorders (2013-2022) ($MN)
Table 99 Europe Drug Discovery Technologies Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 100 Europe Drug Discovery Technologies Market Outlook, By Other Applications (2013-2022) ($MN)
Table 101 Europe Drug Discovery Technologies Market Outlook, By End User (2013-2022) ($MN)
Table 102 Europe Drug Discovery Technologies Market Outlook, By Biopharmaceutical Companies (2013-2022) ($MN)
Table 103 Europe Drug Discovery Technologies Market Outlook, By Research Institutes (2013-2022) ($MN)
Table 104 Europe Drug Discovery Technologies Market Outlook, By Biotech Companies (2013-2022) ($MN)
Table 105 Europe Drug Discovery Technologies Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Table 106 Asia Pacific Drug Discovery Technologies Market Outlook, By Country (2013-2022) ($MN)
Table 107 Asia Pacific Drug Discovery Technologies Market Outlook, By Technology (2013-2022) ($MN)
Table 108 Asia Pacific Drug Discovery Technologies Market Outlook, By DNA & Protein Microarrays (2013-2022) ($MN)
Table 109 Asia Pacific Drug Discovery Technologies Market Outlook, By High Throughput Screening (2013-2022) ($MN)
Table 110 Asia Pacific Drug Discovery Technologies Market Outlook, By Genomics (2013-2022) ($MN)
Table 111 Asia Pacific Drug Discovery Technologies Market Outlook, By Biochips (2013-2022) ($MN)
Table 112 Asia Pacific Drug Discovery Technologies Market Outlook, By Proteomic Technologies (2013-2022) ($MN)
Table 113 Asia Pacific Drug Discovery Technologies Market Outlook, ByMicrofluidics (2013-2022) ($MN)
Table 114 Asia Pacific Drug Discovery Technologies Market Outlook, By Metabolomics (2013-2022) ($MN)
Table 115 Asia Pacific Drug Discovery Technologies Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
Table 116 Asia Pacific Drug Discovery Technologies Market Outlook, By Gel Electrophoresis (2013-2022) ($MN)
Table 117 Asia Pacific Drug Discovery Technologies Market Outlook, By Bioanalytical Instruments (2013-2022) ($MN)
Table 118 Asia Pacific Drug Discovery Technologies Market Outlook, By Chromatography (2013-2022) ($MN)
Table 119 Asia Pacific Drug Discovery Technologies Market Outlook, By Bioinformatics (2013-2022) ($MN)
Table 120 Asia Pacific Drug Discovery Technologies Market Outlook, By QPCR (2013-2022) ($MN)
Table 121 Asia Pacific Drug Discovery Technologies Market Outlook, By Combinatorial Chemistry (2013-2022) ($MN)
Table 122 Asia Pacific Drug Discovery Technologies Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
Table 123 Asia Pacific Drug Discovery Technologies Market Outlook, By Nanotechnology (2013-2022) ($MN)
Table 124 Asia Pacific Drug Discovery Technologies Market Outlook, By RNAi (2013-2022) ($MN)
Table 125 Asia Pacific Drug Discovery Technologies Market Outlook, By Nucleic Acid Isolation (2013-2022) ($MN)
Table 126 Asia Pacific Drug Discovery Technologies Market Outlook, By Protein (2013-2022) ($MN)
Table 127 Asia Pacific Drug Discovery Technologies Market Outlook, By Epigenetics (2013-2022) ($MN)
Table 128 Asia Pacific Drug Discovery Technologies Market Outlook, By Cell Based Assays (2013-2022) ($MN)
Table 129 Asia Pacific Drug Discovery Technologies Market Outlook, By Laboratory Information Management Systems (2013-2022) ($MN)
Table 130 Asia Pacific Drug Discovery Technologies Market Outlook, By Application (2013-2022) ($MN)
Table 131 Asia Pacific Drug Discovery Technologies Market Outlook, By Parkinson’s disease (2013-2022) ($MN)
Table 132 Asia Pacific Drug Discovery Technologies Market Outlook, By Cancer (2013-2022) ($MN)
Table 133 Asia Pacific Drug Discovery Technologies Market Outlook, By Central Nervous System Disorders (2013-2022) ($MN)
Table 134 Asia Pacific Drug Discovery Technologies Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 135 Asia Pacific Drug Discovery Technologies Market Outlook, By Other Applications (2013-2022) ($MN)
Table 136 Asia Pacific Drug Discovery Technologies Market Outlook, By End User (2013-2022) ($MN)
Table 137 Asia Pacific Drug Discovery Technologies Market Outlook, By Biopharmaceutical Companies (2013-2022) ($MN)
Table 138 Asia Pacific Drug Discovery Technologies Market Outlook, By Research Institutes (2013-2022) ($MN)
Table 139 Asia Pacific Drug Discovery Technologies Market Outlook, By Biotech Companies (2013-2022) ($MN)
Table 140 Asia Pacific Drug Discovery Technologies Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)
Table 141 RoW Drug Discovery Technologies Market Outlook, By Country (2013-2022) ($MN)
Table 142 RoW Drug Discovery Technologies Market Outlook, By Technology (2013-2022) ($MN)
Table 143 RoW Drug Discovery Technologies Market Outlook, By DNA & Protein Microarrays (2013-2022) ($MN)
Table 144 RoW Drug Discovery Technologies Market Outlook, By High Throughput Screening (2013-2022) ($MN)
Table 145 RoW Drug Discovery Technologies Market Outlook, By Genomics (2013-2022) ($MN)
Table 146 RoW Drug Discovery Technologies Market Outlook, By Biochips (2013-2022) ($MN)
Table 147 RoW Drug Discovery Technologies Market Outlook, By Proteomic Technologies (2013-2022) ($MN)
Table 148 RoW Drug Discovery Technologies Market Outlook, ByMicrofluidics (2013-2022) ($MN)
Table 149 RoW Drug Discovery Technologies Market Outlook, By Metabolomics (2013-2022) ($MN)
Table 150 RoW Drug Discovery Technologies Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
Table 151 RoW Drug Discovery Technologies Market Outlook, By Gel Electrophoresis (2013-2022) ($MN)
Table 152 RoW Drug Discovery Technologies Market Outlook, By Bioanalytical Instruments (2013-2022) ($MN)
Table 153 RoW Drug Discovery Technologies Market Outlook, By Chromatography (2013-2022) ($MN)
Table 154 RoW Drug Discovery Technologies Market Outlook, By Bioinformatics (2013-2022) ($MN)
Table 155 RoW Drug Discovery Technologies Market Outlook, By QPCR (2013-2022) ($MN)
Table 156 RoW Drug Discovery Technologies Market Outlook, By Combinatorial Chemistry (2013-2022) ($MN)
Table 157 RoW Drug Discovery Technologies Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
Table 158 RoW Drug Discovery Technologies Market Outlook, By Nanotechnology (2013-2022) ($MN)
Table 159 RoW Drug Discovery Technologies Market Outlook, By RNAi (2013-2022) ($MN)
Table 160 RoW Drug Discovery Technologies Market Outlook, By Nucleic Acid Isolation (2013-2022) ($MN)
Table 161 RoW Drug Discovery Technologies Market Outlook, By Protein (2013-2022) ($MN)
Table 162 RoW Drug Discovery Technologies Market Outlook, By Epigenetics (2013-2022) ($MN)
Table 163 RoW Drug Discovery Technologies Market Outlook, By Cell Based Assays (2013-2022) ($MN)
Table 164 RoW Drug Discovery Technologies Market Outlook, By Laboratory Information Management Systems (2013-2022) ($MN)
Table 165 RoW Drug Discovery Technologies Market Outlook, By Application (2013-2022) ($MN)
Table 166 RoW Drug Discovery Technologies Market Outlook, By Parkinson’s disease (2013-2022) ($MN)
Table 167 RoW Drug Discovery Technologies Market Outlook, By Cancer (2013-2022) ($MN)
Table 168 RoW Drug Discovery Technologies Market Outlook, By Central Nervous System Disorders (2013-2022) ($MN)
Table 169 RoW Drug Discovery Technologies Market Outlook, By Cardiovascular Diseases (2013-2022) ($MN)
Table 170 RoW Drug Discovery Technologies Market Outlook, By Other Applications (2013-2022) ($MN)
Table 171 RoW Drug Discovery Technologies Market Outlook, By End User (2013-2022) ($MN)
Table 172 RoW Drug Discovery Technologies Market Outlook, By Biopharmaceutical Companies (2013-2022) ($MN)
Table 173 RoW Drug Discovery Technologies Market Outlook, By Research Institutes (2013-2022) ($MN)
Table 174 RoW Drug Discovery Technologies Market Outlook, By Biotech Companies (2013-2022) ($MN)
Table 175 RoW Drug Discovery Technologies Market Outlook, By Pharmaceutical Companies (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report